American Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Neogen
NEOG
|
+$12.3M |
| 2 |
ResMed
RMD
|
+$4.19M |
| 3 |
DexCom
DXCM
|
+$3.52M |
| 4 |
Cerence
CRNC
|
+$3.47M |
| 5 |
Paycom
PAYC
|
+$2.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$26.4M |
| 2 |
NATI
National Instruments Corp
NATI
|
+$26.3M |
| 3 |
Fortinet
FTNT
|
+$19.4M |
| 4 |
Idexx Laboratories
IDXX
|
+$12M |
| 5 |
Icon
ICLR
|
+$9.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 47.04% |
| 2 | Healthcare | 29.16% |
| 3 | Industrials | 11.19% |
| 4 | Financials | 6.68% |
| 5 | Consumer Discretionary | 3.42% |
Similar funds
American Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, American Capital Management held 64 positions worth $2.59B, down 9.9% from $2.88B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
American Capital Management withdrew a net $88.6M in Q3 2023, closing 1 position and reducing 34 holdings. Its most notable exit was National Instruments Corp, an estimated $26.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 47% of assets, down from 49% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, American Capital Management added an estimated $12.3M to Neogen.
- American Capital Management added most to Neogen in Q3 2023, an estimated $12.3M increase.
- American Capital Management's biggest Q3 2023 reduction was Manhattan Associates, cutting an estimated $26.4M.
- American Capital Management fully exited National Instruments Corp in Q3 2023, selling an estimated $26.3M.
- American Capital Management's ten largest holdings make up 49% of its $2.59B portfolio in Q3 2023.
- American Capital Management opened 0 new positions and closed 1 in Q3 2023.
- American Capital Management's portfolio value fell 9.9% quarter-over-quarter to $2.59B.
Based on American Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.